Focused &
Specialized
Clinical trial sponsors working in oncology, hematology, IBD, infectious diseases, multiple sclerosis, and many rare diseases, rely on PSI’s guidance and experience, knowing we’re specialized and committed to delivering some of the most complex clinical projects in the industry.
Core Therapeutic Areas
Oncology
Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, and other Oncology indications.
Hematology
Multiple Myeloma, Lymphomas, Leukemias, and other oncohematological indications.
Rare Diseases
Hemophilia A & B, Von Willebrand Disease, Thrombocytopenia, Polycythemia Vera, Paroxysmal Nocturnal Hemoglobinuria (PNH).
Strategies for Working with NGS Testing on Site in China
Did you know that NGS testing in China can be can be expedited with the right site relationships?
Read MoreHow to Boost Patient Enrollment in a Global IBD Trial
For one of the largest-ever global IBD trials, we knew our sponsor’s success depended on not only identifying the right sites but also keeping them...
Read MoreLearn How PSI Delivered 10 Global Studies in MS & IBD for a Future Blockbuster Drug
A Phase 2/3 study in relapsing multiple sclerosis patients was failing to recruit, so the sponsor, a global pharmaceutical company, engaged PSI to get enrollment...
Read MoreComplete Enrollment of IBD Studies on or Ahead of Time
The number of IBD trials initiated per year grows every year, meaning competition for sites and patients alike. To make sure one of our longtime...
Read MoreThe PSI Advantage
PSI was flexible to meet the various challenges in clinical trial conduct. The rapid enrollment of patients and the quick study close out allowed on-time study completion.
Chief Medical Officer